Abstract
Aortic valve disease (AVD) and aortopathy are associated with substantial morbidity and mortality, representing a significant cardiovascular healthcare burden worldwide. These mechanobiological structures are morphogenetically related and function in unison from embryonic development through mature adult tissue homeostasis, serving both coordinated and distinct roles. In addition to sharing common developmental origins, diseases of the aortic valve and proximal thoracic aorta often present together clinically. Current research efforts are focused on identifying etiologic factors and elucidating pathogenesis, including genetic predisposition, maladaptive cell-matrix remodeling processes, and hemodynamic and biomechanical perturbations. Here, we review the impact of these processes as they pertain to translational research efforts, emphasizing the overlapping relationship of these two disease processes. The successful application of new therapeutic strategies and novel tissue bioprostheses for AVD and/or aortopathy will require an understanding and integration of molecular and biomechanical processes for both diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006). Burden of valvular heart diseases: a population-based study. Lancet, 368(9540), 1005–1011. doi:10.1016/S0140-6736(06)69208-8.
Rajamannan, N. M., Gersh, B., & Bonow, R. O. (2003). Calcific aortic stenosis: from bench to the bedside—emerging clinical and cellular concepts. Heart, 89(7), 801–805.
Celermajer, D. S., Chow, C. K., Marijon, E., Anstey, N. M., & Woo, K. S. (2012). Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. Journal of the American College of Cardiology, 60(14), 1207–1216. doi:10.1016/j.jacc.2012.03.074.
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., Fullerton, H. J., Gillespie, C., Hailpern, S. M., Heit, J. A., Howard, V. J., Huffman, M. D., Judd, S. E., Kissela, B. M., Kittner, S. J., Lackland, D. T., Lichtman, J. H., Lisabeth, L. D., Mackey, R. H., Magid, D. J., Marcus, G. M., Marelli, A., Matchar, D. B., McGuire, D. K., Mohler, E. R., 3rd, Moy, C. S., Mussolino, M. E., Neumar, R. W., Nichol, G., Pandey, D. K., Paynter, N. P., Reeves, M. J., Sorlie, P. D., Stein, J., Towfighi, A., Turan, T. N., Virani, S. S., Wong, N. D., Woo, D., Turner, M. B., American Heart Association Statistics C, & Stroke Statistics, S. (2014). Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation, 129(3), e28–e292. doi:10.1161/01.cir.0000441139.02102.80.
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande−Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O’Brien, K. D., Schoen, F. J., Towler, D. A., Yoganathan, A. P., & Otto, C. M. (2011). Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease—2011 update. Circulation, 124(16), 1783–1791. doi:10.1161/CIRCULATIONAHA.110.006767.
Horne, B. D., Camp, N. J., Muhlestein, J. B., & Cannon-Albright, L. A. (2004). Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation, 110(19), 3143–3148. doi:10.1161/01.CIR.0000147189.85636.C3.
Roberts, W. C. (1970). The congenitally bicuspid aortic valve. A study of 85 autopsy cases. American Journal of Cardiology, 26(1), 72–83.
Schoen, F. J. (2008). Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation, 118(18), 1864–1880. doi:10.1161/CIRCULATIONAHA.108.805911.
Momma, K. (2010). Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. The American Journal of Cardiology, 105(11), 1617–1624. doi:10.1016/j.amjcard. 2010.01.333.
Pierpont, M. E., Markwald, R. R., & Lin, A. E. (2000). Genetic aspects of atrioventricular septal defects. American Journal of Medical Genetics, 97(4), 289–296.
Sachdev, V., Matura, L. A., Sidenko, S., Ho, V. B., Arai, A. E., Rosing, D. R., & Bondy, C. A. (2008). Aortic valve disease in Turner syndrome. Journal of the American College of Cardiology, 51(19), 1904–1909. doi:10.1016/j.jacc.2008.02.035.
Calloway, T. J., Martin, L. J., Zhang, X., Tandon, A., Benson, D. W., & Hinton, R. B. (2011). Risk factors for aortic valve disease in bicuspid aortic valve: a family-based study. American Journal of Medical Genetics Part A, 155A(5), 1015–1020. doi:10.1002/ajmg.a.33974.
McBride, K. L., Pignatelli, R., Lewin, M., Ho, T., Fernbach, S., Menesses, A., Lam, W., Leal, S. M., Kaplan, N., Schliekelman, P., Towbin, J. A., & Belmont, J. W. (2005). Inheritance analysis of congenital left ventricular outflow tract obstruction malformations: Segregation, multiplex relative risk, and heritability. American Journal of Medical Genetics Part A, 134A(2), 180–186. doi:10.1002/ajmg.a.30602.
Garg, V., Muth, A. N., Ransom, J. F., Schluterman, M. K., Barnes, R., King, I. N., Grossfeld, P. D., & Srivastava, D. (2005). Mutations in NOTCH1 cause aortic valve disease. Nature, 437(7056), 270–274. doi:10.1038/nature03940.
Eronen, M., Peippo, M., Hiippala, A., Raatikka, M., Arvio, M., Johansson, R., & Kahkonen, M. (2002). Cardiovascular manifestations in 75 patients with Williams syndrome. Journal of Medical Genetics, 39(8), 554–558.
Guo, D. C., Pannu, H., Tran-Fadulu, V., Papke, C. L., Yu, R. K., Avidan, N., Bourgeois, S., Estrera, A. L., Safi, H. J., Sparks, E., Amor, D., Ades, L., McConnell, V., Willoughby, C. E., Abuelo, D., Willing, M., Lewis, R. A., Kim, D. H., Scherer, S., Tung, P. P., Ahn, C., Buja, L. M., Raman, C. S., Shete, S. S., & Milewicz, D. M. (2007). Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nature Genetics, 39(12), 1488–1493. doi:10.1038/ng.2007.6.
Nistri, S., Porciani, M. C., Attanasio, M., Abbate, R., Gensini, G. F., & Pepe, G. (2012). Association of Marfan syndrome and bicuspid aortic valve: frequency and outcome. International Journal of Cardiology, 155(2), 324–325. doi:10.1016/j.ijcard.2011.12.009.
Tan, H. L., Glen, E., Topf, A., Hall, D., O’Sullivan, J. J., Sneddon, L., Wren, C., Avery, P., Lewis, R. J., ten Dijke, P., Arthur, H. M., Goodship, J. A., & Keavney, B. D. (2012). Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation. Human Mutation, 33(4), 720–727. doi:10.1002/humu.22030.
Freeman, R. V., & Otto, C. M. (2005). Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation, 111(24), 3316–3326. doi:10.1161/CIRCULATIONAHA.104.486738.
Donald, D., Heistad, C. S., Carabello, B. A., Gould, S. T., Srigunapalan, S., Craig, A., Towler, D. A., Weiss, R. M., Miller, J. D., Lindman, B. R., Bonow, R. O., Otto, C. M., & Demer, L. L. (2013). Compendium on aortic valve disease. Circulation Research, 113, 176–237.
Yutzey, K. E., Demer, L. L., Body, S. C., Huggins, G. S., Towler, D. A., Giachelli, C. M., Hofmann-Bowman, M. A., Mortlock, D. P., Rogers, M. B., Sadeghi, M. M., & Aikawa, E. (2014). Calcific aortic valve disease: a consensus summary from the alliance of investigators on calcific aortic valve disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(11), 2387–2393. doi:10.1161/ATVBAHA.114.302523.
Rogers, A. M., Hermann, L. K., Booher, A. M., Nienaber, C. A., Williams, D. M., Kazerooni, E. A., Froehlich, J. B., O’Gara, P. T., Montgomery, D. G., Cooper, J. V., Harris, K. M., Hutchison, S., Evangelista, A., Isselbacher, E. M., Eagle, K. A., & Investigators, I. (2011). Sensitivity of the aortic dissection detection risk score, a novel guideline-based tool for identification of acute aortic dissection at initial presentation: results from the international registry of acute aortic dissection. Circulation, 123(20), 2213–2218. doi:10.1161/CIRCULATIONAHA.110.988568.
Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Jr., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., Kazerooni, E. A., Kouchoukos, N. T., Lytle, B. W., Milewicz, D. M., Reich, D. L., Sen, S., Shinn, J. A., Svensson, L. G., & Williams, D. M. (2010). 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation, 121(13), e266–e369. doi:10.1161/CIR.0b013e3181d4739e.
Svensson, L. G., & Rodriguez, E. R. (2005). Aortic organ disease epidemic, and why do balloons pop? Circulation, 112(8), 1082–1084. doi:10.1161/CIRCULATIONAHA.105.564682.
Tadros, T. M., Klein, M. D., & Shapira, O. M. (2009). Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation, 119(6), 880–890. doi:10.1161/CIRCULATIONAHA.108.795401.
Milewicz, D. M., Guo, D. C., Tran-Fadulu, V., Lafont, A. L., Papke, C. L., Inamoto, S., Kwartler, C. S., & Pannu, H. (2008). Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annual Review of Genomics and Human Genetics, 9, 283–302. doi:10.1146/annurev.genom.8.080706.092303.
Milewicz, D. M., Chen, H., Park, E. S., Petty, E. M., Zaghi, H., Shashidhar, G., Willing, M., & Patel, V. (1998). Reduced penetrance and variable expressivity of familial thoracic aortic aneurysms/dissections. The American Journal of Cardiology, 82(4), 474–479.
Pape, L. A., Tsai, T. T., Isselbacher, E. M., Oh, J. K., O’Gara, P. T., Evangelista, A., Fattori, R., Meinhardt, G., Trimarchi, S., Bossone, E., Suzuki, T., Cooper, J. V., Froehlich, J. B., Nienaber, C. A., & Eagle, K. A. (2007). Aortic diameter > or =5.5 cm is not a good predictor of type A aortic dissection: observations from the International Registry of Acute Aortic Dissection (IRAD). Circulation, 116(10), 1120–1127. doi:10.1161/CIRCULATIONAHA.107.702720.
Dietz, H. C., Cutting, G. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G. M., Puffenberger, E. G., Hamosh, A., Nanthakumar, E. J., Curristin, S. M., et al. (1991). Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature, 352(6333), 337–339. doi:10.1038/352337a0.
Szabo, Z., Crepeau, M. W., Mitchell, A. L., Stephan, M. J., Puntel, R. A., Yin Loke, K., Kirk, R. C., & Urban, Z. (2006). Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene. Journal of Medical Genetics, 43(3), 255–258. doi:10.1136/jmg.2005.034157.
Wang, L., Guo, D. C., Cao, J., Gong, L., Kamm, K. E., Regalado, E., Li, L., Shete, S., He, W. Q., Zhu, M. S., Offermanns, S., Gilchrist, D., Elefteriades, J., Stull, J. T., & Milewicz, D. M. (2010). Mutations in myosin light chain kinase cause familial aortic dissections. American Journal of Human Genetics, 87(5), 701–707. doi:10.1016/j.ajhg.2010.10.006.
Zhu, L., Vranckx, R., Khau Van Kien, P., Lalande, A., Boisset, N., Mathieu, F., Wegman, M., Glancy, L., Gasc, J. M., Brunotte, F., Bruneval, P., Wolf, J. E., Michel, J. B., & Jeunemaitre, X. (2006). Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nature Genetics, 38(3), 343–349. doi:10.1038/ng1721.
Vaughan, C. J., Casey, M., He, J., Veugelers, M., Henderson, K., Guo, D., Campagna, R., Roman, M. J., Milewicz, D. M., Devereux, R. B., & Basson, C. T. (2001). Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation, 103(20), 2469–2475.
Guo, D., Hasham, S., Kuang, S. Q., Vaughan, C. J., Boerwinkle, E., Chen, H., Abuelo, D., Dietz, H. C., Basson, C. T., Shete, S. S., & Milewicz, D. M. (2001). Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13–14. Circulation, 103(20), 2461–2468.
Loeys, B. L., Chen, J., Neptune, E. R., Judge, D. P., Podowski, M., Holm, T., Meyers, J., Leitch, C. C., Katsanis, N., Sharifi, N., Xu, F. L., Myers, L. A., Spevak, P. J., Cameron, D. E., De Backer, J., Hellemans, J., Chen, Y., Davis, E. C., Webb, C. L., Kress, W., Coucke, P., Rifkin, D. B., De Paepe, A. M., & Dietz, H. C. (2005). A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nature Genetics, 37(3), 275–281. doi:10.1038/ng1511.
Purnell, R., Williams, I., Von Oppell, U., & Wood, A. (2005). Giant aneurysms of the sinuses of Valsalva and aortic regurgitation in a patient with Noonan’s syndrome. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery, 28(2), 346–348. doi:10.1016/j.ejcts.2005.05.004.
McElhinney, D. B., Krantz, I. D., Bason, L., Piccoli, D. A., Emerick, K. M., Spinner, N. B., & Goldmuntz, E. (2002). Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation, 106(20), 2567–2574.
Boileau, C., Guo, D. C., Hanna, N., Regalado, E. S., Detaint, D., Gong, L., Varret, M., Prakash, S. K., Li, A. H., d’Indy, H., Braverman, A. C., Grandchamp, B., Kwartler, C. S., Gouya, L., Santos-Cortez, R. L., Abifadel, M., Leal, S. M., Muti, C., Shendure, J., Gross, M. S., Rieder, M. J., Vahanian, A., Nickerson, D. A., Michel, J. B., Jondeau, G., & Milewicz, D. M. (2012). TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nature Genetics, 44(8), 916–921. doi:10.1038/ng.2348.
van de Laar, I. M., Oldenburg, R. A., Pals, G., Roos-Hesselink, J. W., de Graaf, B. M., Verhagen, J. M., Hoedemaekers, Y. M., Willemsen, R., Severijnen, L. A., Venselaar, H., Vriend, G., Pattynama, P. M., Collee, M., Majoor-Krakauer, D., Poldermans, D., Frohn-Mulder, I. M., Micha, D., Timmermans, J., Hilhorst-Hofstee, Y., Bierma-Zeinstra, S. M., Willems, P. J., Kros, J. M., Oei, E. H., Oostra, B. A., Wessels, M. W., & Bertoli-Avella, A. M. (2011). Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nature Genetics, 43(2), 121–126. doi:10.1038/ng.744.
Doyle, A. J., Doyle, J. J., Bessling, S. L., Maragh, S., Lindsay, M. E., Schepers, D., Gillis, E., Mortier, G., Homfray, T., Sauls, K., Norris, R. A., Huso, N. D., Leahy, D., Mohr, D. W., Caulfield, M. J., Scott, A. F., Destree, A., Hennekam, R. C., Arn, P. H., Curry, C. J., Van Laer, L., McCallion, A. S., Loeys, B. L., & Dietz, H. C. (2012). Mutations in the TGF-beta repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nature Genetics, 44(11), 1249–1254. doi:10.1038/ng.2421.
Teekakirikul, P., Milewicz, D. M., Miller, D. T., Lacro, R. V., Regalado, E. S., Rosales, A. M., Ryan, D. P., Toler, T. L., & Lin, A. E. (2013). Thoracic aortic disease in two patients with juvenile polyposis syndrome and SMAD4 mutations. American Journal of Medical Genetics Part A, 161A(1), 185–191. doi:10.1002/ajmg.a.35659.
Guo, D. C., Regalado, E., Casteel, D. E., Santos-Cortez, R. L., Gong, L., Kim, J. J., Dyack, S., Horne, S. G., Chang, G., Jondeau, G., Boileau, C., Coselli, J. S., Li, Z., Leal, S. M., Shendure, J., Rieder, M. J., Bamshad, M. J., Nickerson, D. A., Kim, C., & Milewicz, D. M. (2013). Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. American Journal of Human Genetics, 93(2), 398–404. doi:10.1016/j.ajhg.2013.06.019.
McKellar, S. H., Tester, D. J., Yagubyan, M., Majumdar, R., Ackerman, M. J., & Sundt, T. M., 3rd. (2007). Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. Journal of Thoracic and Cardiovascular Surgery, 134(2), 290–296. doi:10.1016/j.jtcvs.2007.02.041.
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Jr., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995). A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 92(5), 1355–1374.
Albini, P. T., Segura, A. M., Liu, G., Minard, C. G., Coselli, J. S., Milewicz, D. M., Shen, Y. H., & LeMaire, S. A. (2014). Advanced atherosclerosis is associated with increased medial degeneration in sporadic ascending aortic aneurysms. Atherosclerosis, 232(2), 361–368. doi:10.1016/j.atherosclerosis.2013.10.035.
Biasucci, L. M., & Cdc, A. (2004). CDC/AHA Workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper. Circulation, 110(25), e560–e567. doi:10.1161/01.CIR.0000148983.88334.80.
Golledge, J., & Norman, P. E. (2010). Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arteriosclerosis, Thrombosis, and Vascular Biology, 30(6), 1075–1077. doi:10.1161/ATVBAHA.110.206573.
Fedak, P. W., Verma, S., David, T. E., Leask, R. L., Weisel, R. D., & Butany, J. (2002). Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation, 106(8), 900–904.
Russo, C. F., Cannata, A., Lanfranconi, M., Vitali, E., Garatti, A., & Bonacina, E. (2008). Is aortic wall degeneration related to bicuspid aortic valve anatomy in patients with valvular disease? Journal of Thoracic and Cardiovascular Surgery, 136(4), 937–942. doi:10.1016/j.jtcvs.2007.11.072.
Siu, S. C., & Silversides, C. K. (2010). Bicuspid aortic valve disease. Journal of the American College of Cardiology, 55(25), 2789–2800. doi:10.1016/j.jacc.2009.12.068.
Cattell, M. A., Hasleton, P. S., & Anderson, J. C. (1994). Glycosaminoglycan content is increased in dissecting aneurysms of human thoracic aorta. Clinica Chimica Acta, 226(1), 29–46.
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O’Brien, K. D. (1994). Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation, 90(2), 844–853.
Hinton, R. B. (2012). Bicuspid aortic valve and thoracic aortic aneurysm: three patient populations, two disease phenotypes, and one shared genotype. Cardiology Research and Practice, 2012, 926975. doi:10.1155/2012/926975.
Otto, C. M. (2006). Valvular aortic stenosis: disease severity and timing of intervention. Journal of the American College of Cardiology, 47(11), 2141–2151. doi:10.1016/j.jacc.2006.03.002.
Tzemos, N., Therrien, J., Yip, J., Thanassoulis, G., Tremblay, S., Jamorski, M. T., Webb, G. D., & Siu, S. C. (2008). Outcomes in adults with bicuspid aortic valves. JAMA, 300(11), 1317–1325. doi:10.1001/jama.300.11.1317.
Stephens, E. H., de Jonge, N., McNeill, M. P., Durst, C. A., & Grande-Allen, K. J. (2010). Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition. Tissue Engineering Part A, 16(3), 867–878. doi:10.1089/ten.TEA.2009.0288.
Krishnamurthy, V. K., Guilak, F., Narmoneva, D. A., & Hinton, R. B. (2011). Regional structure-function relationships in mouse aortic valve tissue. Journal of Biomechanics, 44(1), 77–83. doi:10.1016/j.jbiomech.2010.08.026.
Pezet, M., Jacob, M. P., Escoubet, B., Gheduzzi, D., Tillet, E., Perret, P., Huber, P., Quaglino, D., Vranckx, R., Li, D. Y., Starcher, B., Boyle, W. A., Mecham, R. P., & Faury, G. (2008). Elastin haploinsufficiency induces alternative aging processes in the aorta. Rejuvenation Research, 11(1), 97–112. doi:10.1089/rej.2007.0587.
Roberts, W. C., Ko, J. M., & Hamilton, C. (2005). Comparison of valve structure, valve weight, and severity of the valve obstruction in 1849 patients having isolated aortic valve replacement for aortic valve stenosis (with or without associated aortic regurgitation) studied at 3 different medical centers in 2 different time periods. Circulation, 112(25), 3919–3929. doi:10.1161/CIRCULATIONAHA.105.543280.
Roberts, W. C., & Ko, J. M. (2005). Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation, 111(7), 920–925. doi:10.1161/01.CIR.0000155623.48408.C5.
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997). Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. Journal of the American College of Cardiology, 29(3), 630–634.
Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J., & Siscovick, D. S. (1999). Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. New England Journal of Medicine, 341(3), 142–147. doi:10.1056/NEJM199907153410302.
Albornoz, G., Coady, M. A., Roberts, M., Davies, R. R., Tranquilli, M., Rizzo, J. A., & Elefteriades, J. A. (2006). Familial thoracic aortic aneurysms and dissections—incidence, modes of inheritance, and phenotypic patterns. The Annals of Thoracic Surgery, 82(4), 1400–1405. doi:10.1016/j.athoracsur.2006.04.098.
Lasheras, J. C. (2007). The biomechanics of arterial aneurysms. Annual Review of Fluid Mechanics, 39, 293–319. doi:10.1146/annurev.fluid.39.050905.110128.
Holmes, K. W., Maslen, C. L., Kindem, M., Kroner, B. L., Song, H. K., Ravekes, W., Dietz, H. C., Weinsaft, J. W., Roman, M. J., Devereux, R. B., Pyeritz, R. E., Bavaria, J., Milewski, K., Milewicz, D., LeMaire, S. A., Hendershot, T., Eagle, K. A., Tolunay, H. E., Desvigne-Nickens, P., & Silberbach, M. (2013). GenTAC registry report: gender differences among individuals with genetically triggered thoracic aortic aneurysm and dissection. American Journal of Medical Genetics Part A, 161A(4), 779–786. doi:10.1002/ajmg.a.35836.
Nassimiha, D., Aronow, W. S., Ahn, C., & Goldman, M. E. (2001). Association of coronary risk factors with progression of valvular aortic stenosis in older persons. American Journal of Cardiology, 87(11), 1313–1314.
Ngo, M. V., Gottdiener, J. S., Fletcher, R. D., Fernicola, D. J., & Gersh, B. J. (2001). Smoking and obesity are associated with the progression of aortic stenosis. The American Journal of Geriatric Cardiology, 10(2), 86–90.
Towler, D. A. (2013). Molecular and cellular aspects of calcific aortic valve disease. Circulation Research, 113(2), 198–208. doi:10.1161/CIRCRESAHA.113.300155.
Cripe, L., Andelfinger, G., Martin, L. J., Shooner, K., & Benson, D. W. (2004). Bicuspid aortic valve is heritable. Journal of the American College of Cardiology, 44(1), 138–143. doi:10.1016/j.jacc.2004.03.050.
Webb, S., Qayyum, S. R., Anderson, R. H., Lamers, W. H., & Richardson, M. K. (2003). Septation and separation within the outflow tract of the developing heart. Journal of Anatomy, 202(4), 327–342.
Mjaatvedt, C. H., Nakaoka, T., Moreno-Rodriguez, R., Norris, R. A., Kern, M. J., Eisenberg, C. A., Turner, D., & Markwald, R. R. (2001). The outflow tract of the heart is recruited from a novel heart-forming field. Developmental Biology, 238(1), 97–109. doi:10.1006/dbio.2001.0409.
Kirby, M. L., Gale, T. F., & Stewart, D. E. (1983). Neural crest cells contribute to normal aorticopulmonary septation. Science, 220(4601), 1059–1061.
Majesky, M. W. (2007). Developmental basis of vascular smooth muscle diversity. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(6), 1248–1258. doi:10.1161/ATVBAHA.107.141069.
Krishnamurthy, V. K., Evans, A. N., Wansapura, J. P., Osinska, H., Maddy, K. E., Biechler, S. V., Narmoneva, D. A., Goodwin, R. L., & Hinton, R. B. (2014). Asymmetric cell-matrix and biomechanical abnormalities in elastin insufficiency induced aortopathy. Annals of Biomedical Engineering. doi:10.1007/s10439-014-1072-y.
Yacoub, M. H., Kilner, P. J., Birks, E. J., & Misfeld, M. (1999). The aortic outflow and root: a tale of dynamism and crosstalk. Annals of Thoracic Surgery, 68(3 Suppl), S37–S43.
Aikawa, E., Whittaker, P., Farber, M., Mendelson, K., Padera, R. F., Aikawa, M., & Schoen, F. J. (2006). Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation, 113(10), 1344–1352. doi:10.1161/CIRCULATIONAHA.105.591768.
Hinton, R. B., Jr., Lincoln, J., Deutsch, G. H., Osinska, H., Manning, P. B., Benson, D. W., & Yutzey, K. E. (2006). Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circulation Research, 98(11), 1431–1438. doi:10.1161/01.RES.0000224114.65109.4e.
Votteler, M., Berrio, D. A., Horke, A., Sabatier, L., Reinhardt, D. P., Nsair, A., Aikawa, E., & Schenke-Layland, K. (2013). Elastogenesis at the onset of human cardiac valve development. Development, 140(11), 2345–2353. doi:10.1242/dev.093500.
Gross, L., & Kugel, M.A. (1931). Topographic anatomy and histology of the valves in the human heart. American Journal of Pathology, 7(5), 445–474 447.
Zimmerman, J., & Bailey, C. P. (1962). The surgical significance of the fibrous skeleton of the heart. Journal of Thoracic and Cardiovascular Surgery, 44, 12.
Hinton, R. B., & Yutzey, K. E. (2011). Heart valve structure and function in development and disease. Annual Review of Physiology, 73, 29–46. doi:10.1146/annurev-physiol-012110-142145.
Latif, N., Sarathchandra, P., Taylor, P. M., Antoniw, J., & Yacoub, M. H. (2005). Localization and pattern of expression of extracellular matrix components in human heart valves. Journal of Heart Valve Disease, 14(2), 218–227.
Schoen, F. J. (1997). Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. Journal of Heart Valve Disease, 6(1), 1–6.
Anderson, R. H. (2000). Clinical anatomy of the aortic root. Heart, 84(6), 670–673.
Armstrong, E. J., & Bischoff, J. (2004). Heart valve development: endothelial cell signaling and differentiation. Circulation Research, 95(5), 459–470. doi:10.1161/01.RES.0000141146.95728.da.
de Lange, F. J., Moorman, A. F., Anderson, R. H., Manner, J., Soufan, A. T., de Gier-de, V. C., Schneider, M. D., Webb, S., van den Hoff, M. J., & Christoffels, V. M. (2004). Lineage and morphogenetic analysis of the cardiac valves. Circulation Research, 95(6), 645–654. doi:10.1161/01.RES.0000141429.13560.cb.
Lincoln, J., Alfieri, C. M., & Yutzey, K. E. (2004). Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Developmental Dynamics: An Official Publication of the American Association of Anatomists, 230(2), 239–250. doi:10.1002/dvdy.20051.
Liu, A. C., Joag, V. R., & Gotlieb, A. I. (2007). The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. American Journal of Pathology, 171(5), 1407–1418. doi:10.2353/ajpath.2007.070251.
Filip, D. A., Radu, A., & Simionescu, M. (1986). Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circulation Research, 59(3), 310–320.
Latif, N., Sarathchandra, P., Chester, A. H., & Yacoub, M. H. (2014). Expression of smooth muscle cell markers and co-activators in calcified aortic valves. European Heart Journal. doi:10.1093/eurheartj/eht547.
Butcher, J. T., Tressel, S., Johnson, T., Turner, D., Sorescu, G., Jo, H., & Nerem, R. M. (2006). Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: influence of shear stress. Arteriosclerosis, Thrombosis, and Vascular Biology, 26(1), 69–77. doi:10.1161/01.ATV.0000196624.70507.0d.
Majesky, M. W., Dong, X. R., Hoglund, V., Mahoney, W. M., Jr., & Daum, G. (2011). The adventitia: a dynamic interface containing resident progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(7), 1530–1539. doi:10.1161/ATVBAHA.110.221549.
Ross, R., & Bornstein, P. (1969). The elastic fiber. I. The separation and partial characterization of its macromolecular components. Journal of Cell Biology, 40(2), 366–381.
Kielty, C. M., Sherratt, M. J., & Shuttleworth, C. A. (2002). Elastic fibres. Journal of Cell Science, 115(Pt 14), 2817–2828.
Karnik, S. K., Brooke, B. S., Bayes-Genis, A., Sorensen, L., Wythe, J. D., Schwartz, R. S., Keating, M. T., & Li, D. Y. (2003). A critical role for elastin signaling in vascular morphogenesis and disease. Development, 130(2), 411–423.
Li, D. Y., Brooke, B., Davis, E. C., Mecham, R. P., Sorensen, L. K., Boak, B. B., Eichwald, E., & Keating, M. T. (1998). Elastin is an essential determinant of arterial morphogenesis. Nature, 393(6682), 276–280. doi:10.1038/30522.
Aikawa, E., Aikawa, M., Libby, P., Figueiredo, J. L., Rusanescu, G., Iwamoto, Y., Fukuda, D., Kohler, R. H., Shi, G. P., Jaffer, F. A., & Weissleder, R. (2009). Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation, 119(13), 1785–1794. doi:10.1161/CIRCULATIONAHA.108.827972.
Rothenburger, M., Volker, W., Vischer, P., Glasmacher, B., Scheld, H. H., & Deiwick, M. (2002). Ultrastructure of proteoglycans in tissue-engineered cardiovascular structures. Tissue Engineering, 8(6), 1049–1056. doi:10.1089/107632702320934146.
Kinsella, M. G., Bressler, S. L., & Wight, T. N. (2004). The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Critical Reviews in Eukaryotic Gene Expression, 14(3), 203–234.
Iozzo, R. V., & Schaefer, L. (2010). Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS Journal, 277(19), 3864–3875. doi:10.1111/j.1742-4658.2010.07797.x.
Duran, C. M., & Gunning, A. J. (1968). The vascularization of the heart valves: a comparative study. Cardiovascular Research, 2(3), 290–296.
Simionescu, D. T., Lovekamp, J. J., & Vyavahare, N. R. (2003). Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. The Journal of Heart Valve Disease, 12(2), 217–225.
Azeloglu, E. U., Albro, M. B., Thimmappa, V. A., Ateshian, G. A., & Costa, K. D. (2008). Heterogeneous transmural proteoglycan distribution provides a mechanism for regulating residual stresses in the aorta. American Journal of Physiology—Heart and Circulatory Physiology, 294(3), H1197–H1205. doi:10.1152/ajpheart.01027.2007.
Stephens, E. H., Saltarrelli, J. G., Baggett, L. S., Nandi, I., Kuo, J. J., Davis, A. R., Olmsted-Davis, E. A., Reardon, M. J., Morrisett, J. D., & Grande-Allen, K. J. (2011). Differential proteoglycan and hyaluronan distribution in calcified aortic valves. Cardiovascular Pathology: The Official Journal of the Society for Cardiovascular Pathology, 20(6), 334–342. doi:10.1016/j.carpath.2010.10.002.
Krishnamurthy, V. K., Opoka, A. M., Kern, C. B., Guilak, F., Narmoneva, D. A., & Hinton, R. B. (2012). Maladaptive matrix remodeling and regional biomechanical dysfunction in a mouse model of aortic valve disease. Matrix Biology: Journal of the International Society for Matrix Biology, 31(3), 197–205. doi:10.1016/j.matbio.2012.01.001.
Kern, C. B., Wessels, A., McGarity, J., Dixon, L. J., Alston, E., Argraves, W. S., Geeting, D., Nelson, C. M., Menick, D. R., & Apte, S. S. (2010). Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biology, 29(4), 304–316. doi:10.1016/j.matbio.2010.01.005.
Mohamed, S. A., Sievers, H. H., Hanke, T., Richardt, D., Schmidtke, C., Charitos, E. I., Belge, G., & Bullerdiek, J. (2009). Pathway analysis of differentially expressed genes in patients with acute aortic dissection. Biomarker Insights, 4, 81–90.
Heegaard, A. M., Corsi, A., Danielsen, C. C., Nielsen, K. L., Jorgensen, H. L., Riminucci, M., Young, M. F., & Bianco, P. (2007). Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation, 115(21), 2731–2738. doi:10.1161/CIRCULATIONAHA.106.653980.
Ren, P., Zhang, L., Xu, G., Palmero, L. C., Albini, P. T., Coselli, J. S., Shen, Y. H., & LeMaire, S. A. (2013). ADAMTS-1 and ADAMTS-4 levels are elevated in thoracic aortic aneurysms and dissections. The Annals of Thoracic Surgery, 95(2), 570–577. doi:10.1016/j.athoracsur.2012.10.084.
Merrilees, M. J., Beaumont, B. W., Braun, K. R., Thomas, A. C., Kang, I., Hinek, A., Passi, A., & Wight, T. N. (2011). Neointima formed by arterial smooth muscle cells expressing versican variant v3 is resistant to lipid and macrophage accumulation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(6), 1309–1316. doi:10.1161/ATVBAHA.111.225573.
Hinton, R. B., Adelman-Brown, J., Witt, S., Krishnamurthy, V. K., Osinska, H., Sakthivel, B., James, J. F., Li, D. Y., Narmoneva, D. A., Mecham, R. P., & Benson, D. W. (2010). Elastin haploinsufficiency results in progressive aortic valve malformation and latent valve disease in a mouse model. Circulation Research, 107(4), 549–557. doi:10.1161/CIRCRESAHA.110.221358.
Wu, Y. J., La Pierre, D. P., Wu, J., Yee, A. J., & Yang, B. B. (2005). The interaction of versican with its binding partners. Cell Research, 15(7), 483–494. doi:10.1038/sj.cr.7290318.
Hinek, A., & Rabinovitch, M. (1994). 67-kD elastin-binding protein is a protective “companion” of extracellular insoluble elastin and intracellular tropoelastin. Journal of Cell Biology, 126(2), 563–574.
Tseng, H., & Grande-Allen, K. J. (2011). Elastic fibers in the aortic valve spongiosa: a fresh perspective on its structure and role in overall tissue function. Acta Biomaterialia, 7(5), 2101–2108. doi:10.1016/j.actbio.2011.01.022.
Roccabianca, S., Bellini, C., & Humphrey, J. D. (2014). Computational modelling suggests good, bad and ugly roles of glycosaminoglycans in arterial wall mechanics and mechanobiology. Journal of the Royal Society, Interface the Royal Society, 11(97), 20140397. doi:10.1098/rsif.2014.0397.
Huang, R., Merrilees, M. J., Braun, K., Beaumont, B., Lemire, J., Clowes, A. W., Hinek, A., & Wight, T. N. (2006). Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circulation Research, 98(3), 370–377. doi:10.1161/01.RES.0000202051.28319.c8.
Reinboth, B., Hanssen, E., Cleary, E. G., & Gibson, M. A. (2002). Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1. The Journal of Biological Chemistry, 277(6), 3950–3957. doi:10.1074/jbc.M109540200.
Hwang, J. Y., Johnson, P. Y., Braun, K. R., Hinek, A., Fischer, J. W., O’Brien, K. D., Starcher, B., Clowes, A. W., Merrilees, M. J., & Wight, T. N. (2008). Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury. American Journal of Pathology, 173(6), 1919–1928. doi:10.2353/ajpath.2008.070875.
Dupuis, L. E., & Kern, C. B. (2014). Small leucine-rich proteoglycans exhibit unique spatiotemporal expression profiles during cardiac valve development. Developmental Dynamics, 243(4), 601–611. doi:10.1002/dvdy.24100.
Hinek, A., & Wilson, S. E. (2000). Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. American Journal of Pathology, 156(3), 925–938. doi:10.1016/S0002-9440(10)64961-9.
Golda, A., Jurecka, A., & Tylki-Szymanska, A. (2012). Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). International Journal of Cardiology, 158(1), 6–11. doi:10.1016/j.ijcard.2011.06.097.
Rabkin-Aikawa, E., Farber, M., Aikawa, M., & Schoen, F. J. (2004). Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. Journal of Heart Valve Disease, 13(5), 841–847.
Pho, M., Lee, W., Watt, D. R., Laschinger, C., Simmons, C. A., & McCulloch, C. A. (2008). Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. American Journal of Physiology—Heart and Circulatory Physiology, 294(4), H1767–H1778. doi:10.1152/ajpheart.01305.2007.
Aikawa, M., Sivam, P. N., Kuro-o, M., Kimura, K., Nakahara, K., Takewaki, S., Ueda, M., Yamaguchi, H., Yazaki, Y., Periasamy, M., et al. (1993). Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circulation Research, 73(6), 1000–1012.
Owens, G. K., Kumar, M. S., & Wamhoff, B. R. (2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiological Reviews, 84(3), 767–801. doi:10.1152/physrev.00041.2003.
Rosenquist, T. H., & Beall, A. C. (1990). Elastogenic cells in the developing cardiovascular system. Smooth muscle, nonmuscle, and cardiac neural crest. Annals of the New York Academy of Sciences, 588, 106–119.
Walker, G. A., Masters, K. S., Shah, D. N., Anseth, K. S., & Leinwand, L. A. (2004). Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circulation Research, 95(3), 253–260. doi:10.1161/01.RES.0000136520.07995.aa.
Dreger, S. A., Taylor, P. M., Allen, S. P., & Yacoub, M. H. (2002). Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. Journal of Heart Valve Disease, 11(6), 875–880. discussion 880.
Fedak, P. W., de Sa, M. P., Verma, S., Nili, N., Kazemian, P., Butany, J., Strauss, B. H., Weisel, R. D., & David, T. E. (2003). Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. Journal of Thoracic and Cardiovascular Surgery, 126(3), 797–806.
LeMaire, S. A., Wang, X., Wilks, J. A., Carter, S. A., Wen, S., Won, T., Leonardelli, D., Anand, G., Conklin, L. D., Wang, X. L., Thompson, R. W., & Coselli, J. S. (2005). Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. Journal of Surgical Research, 123(1), 40–48. doi:10.1016/j.jss.2004.06.007.
LeMaire, S. A., Pannu, H., Tran-Fadulu, V., Carter, S. A., Coselli, J. S., & Milewicz, D. M. (2007). Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. Nature Clinical Practice. Cardiovascular Medicine, 4(3), 167–171. doi:10.1038/ncpcardio0797.
Ikonomidis, J. S., Jones, J. A., Barbour, J. R., Stroud, R. E., Clark, L. L., Kaplan, B. S., Zeeshan, A., Bavaria, J. E., Gorman, J. H., 3rd, Spinale, F. G., & Gorman, R. C. (2007). Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. Journal of Thoracic and Cardiovascular Surgery, 133(4), 1028–1036. doi:10.1016/j.jtcvs.2006.10.083.
Togashi, M., Tamura, K., Nitta, T., Ishizaki, M., Sugisaki, Y., & Fukuda, Y. (2007). Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves. Pathology International, 57(5), 251–259. doi:10.1111/j.1440-1827.2007.02096.x.
Rabkin, E., Aikawa, M., Stone, J. R., Fukumoto, Y., Libby, P., & Schoen, F. J. (2001). Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation, 104(21), 2525–2532.
Laforest, B., & Nemer, M. (2012). Genetic insights into bicuspid aortic valve formation. Cardiology Research and Practice, 2012, 180297. doi:10.1155/2012/180297.
Molkentin, J. D. (2000). The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. Journal of Biological Chemistry, 275(50), 38949–38952. doi:10.1074/jbc.R000029200.
Thomas, P. S., Sridurongrit, S., Ruiz-Lozano, P., & Kaartinen, V. (2012). Deficient signaling via Alk2 (Acvr1) leads to bicuspid aortic valve development. PLoS ONE, 7(4), e35539. doi:10.1371/journal.pone.0035539.
Lindsay, M. E., Schepers, D., Bolar, N. A., Doyle, J. J., Gallo, E., Fert-Bober, J., Kempers, M. J., Fishman, E. K., Chen, Y., Myers, L., Bjeda, D., Oswald, G., Elias, A. F., Levy, H. P., Anderlid, B. M., Yang, M. H., Bongers, E. M., Timmermans, J., Braverman, A. C., Canham, N., Mortier, G. R., Brunner, H. G., Byers, P. H., Van Eyk, J., Van Laer, L., Dietz, H. C., & Loeys, B. L. (2012). Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nature Genetics, 44(8), 922–927. doi:10.1038/ng.2349.
Conway, S. J., Doetschman, T., & Azhar, M. (2011). The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. ScientificWorldJournal, 11, 1509–1524. doi:10.1100/tsw.2011.132.
Hanada, K., Vermeij, M., Garinis, G. A., de Waard, M. C., Kunen, M. G., Myers, L., Maas, A., Duncker, D. J., Meijers, C., Dietz, H. C., Kanaar, R., & Essers, J. (2007). Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circulation Research, 100(5), 738–746. doi:10.1161/01.RES.0000260181.19449.95.
Ng, C. M., Cheng, A., Myers, L. A., Martinez-Murillo, F., Jie, C., Bedja, D., Gabrielson, K. L., Hausladen, J. M., Mecham, R. P., Judge, D. P., & Dietz, H. C. (2004). TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. The Journal of Clinical Investigation, 114(11), 1586–1592. doi:10.1172/JCI22715.
Weyman, A. E., & Scherrer-Crosbie, M. (2004). Marfan syndrome and mitral valve prolapse. The Journal of Clinical Investigation, 114(11), 1543–1546. doi:10.1172/JCI23701.
Yanagisawa, H., Davis, E. C., Starcher, B. C., Ouchi, T., Yanagisawa, M., Richardson, J. A., & Olson, E. N. (2002). Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature, 415(6868), 168–171. doi:10.1038/415168a.
Munjal, C., Opoka, A. M., Osinska, H., James, J. F., Bressan, G. M., & Hinton, R. B. (2014). TGF-beta mediates early angiogenesis and latent fibrosis in an Emilin1-deficient mouse model of aortic valve disease. Disease Models & Mechanisms, 7(8), 987–996. doi:10.1242/dmm.015255.
Tkatchenko, T. V., Moreno-Rodriguez, R. A., Conway, S. J., Molkentin, J. D., Markwald, R. R., & Tkatchenko, A. V. (2009). Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiological Genomics, 39(3), 160–168. doi:10.1152/physiolgenomics.00078.2009.
Cheek, J. D., Wirrig, E. E., Alfieri, C. M., James, J. F., & Yutzey, K. E. (2012). Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease. Journal of Molecular and Cellular Cardiology, 52(3), 689–700. doi:10.1016/j.yjmcc.2011.12.013.
Hofmann, J. J., Briot, A., Enciso, J., Zovein, A. C., Ren, S., Zhang, Z. W., Radtke, F., Simons, M., Wang, Y., & Iruela-Arispe, M. L. (2012). Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome. Development, 139(23), 4449–4460. doi:10.1242/dev.084871.
Kokubo, H., Miyagawa-Tomita, S., Nakashima, Y., Kume, T., Yoshizumi, M., Nakanishi, T., & Saga, Y. (2013). Hesr2 knockout mice develop aortic valve disease with advancing age. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(3), e84–e92. doi:10.1161/ATVBAHA.112.300573.
Nus, M., MacGrogan, D., Martinez-Poveda, B., Benito, Y., Casanova, J. C., Fernandez-Aviles, F., Bermejo, J., & de la Pompa, J. L. (2011). Diet-induced aortic valve disease in mice haploinsufficient for the Notch pathway effector RBPJK/CSL. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(7), 1580–1588. doi:10.1161/ATVBAHA.111.227561.
Weiss, R. M., Lund, D. D., Chu, Y., Brooks, R. M., Zimmerman, K. A., El Accaoui, R., Davis, M. K., Hajj, G. P., Zimmerman, M. B., & Heistad, D. D. (2013). Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice. PLoS ONE, 8(6), e65201. doi:10.1371/journal.pone.0065201.
Sacks, M. S., David Merryman, W., & Schmidt, D. E. (2009). On the biomechanics of heart valve function. Journal of Biomechanics, 42(12), 1804–1824. doi:10.1016/j.jbiomech.2009.05.015.
Christie, G. W., & Barratt-Boyes, B. G. (1995). Mechanical properties of porcine pulmonary valve leaflets: how do they differ from aortic leaflets? Annals of Thoracic Surgery, 60(2 Suppl), S195–S199.
Billiar, K. L., & Sacks, M. S. (2000). Biaxial mechanical properties of the native and glutaraldehyde-treated aortic valve cusp: Part II–A structural constitutive model. Journal of Biomechanical Engineering, 122(4), 327–335.
Grande, K. J., Cochran, R. P., Reinhall, P. G., & Kunzelman, K. S. (1998). Stress variations in the human aortic root and valve: the role of anatomic asymmetry. Annals of Biomedical Engineering, 26(4), 534–545.
Marom, G., Haj-Ali, R., Rosenfeld, M., Schafers, H. J., & Raanani, E. (2013). Aortic root numeric model: annulus diameter prediction of effective height and coaptation in post-aortic valve repair. Journal of Thoracic and Cardiovascular Surgery, 145(2), 406–411. doi:10.1016/j.jtcvs.2012.01.080. e401.
Hamdan, A., Guetta, V., Konen, E., Goitein, O., Segev, A., Raanani, E., Spiegelstein, D., Hay, I., Di Segni, E., Eldar, M., & Schwammenthal, E. (2012). Deformation dynamics and mechanical properties of the aortic annulus by 4-dimensional computed tomography: insights into the functional anatomy of the aortic valve complex and implications for transcatheter aortic valve therapy. Journal of the American College of Cardiology, 59(2), 119–127. doi:10.1016/j.jacc.2011.09.045.
Vesely, I. (1998). The role of elastin in aortic valve mechanics. Journal of Biomechanics, 31(2), 115–123.
Bellhouse, B. J., & Reid, K. G. (1969). Fluid mechanics of the aortic valve. British Heart Journal, 31(3), 391.
Billiar, K. L., & Sacks, M. S. (2000). Biaxial mechanical properties of the natural and glutaraldehyde treated aortic valve cusp—part I: experimental results. Journal of Biomechanical Engineering, 122(1), 23–30.
Christie, G. W., & Barratt-Boyes, B. G. (1995). Age-dependent changes in the radial stretch of human aortic valve leaflets determined by biaxial testing. Annals of Thoracic Surgery, 60(2 Suppl), S156–S158. discussion S159.
Yap, C. H., Saikrishnan, N., Tamilselvan, G., Vasilyev, N., & Yoganathan, A. P. (2012). The congenital bicuspid aortic valve can experience high-frequency unsteady shear stresses on its leaflet surface. American Journal of Physiology. Heart and Circulatory Physiology, 303(6), H721–H731. doi:10.1152/ajpheart.00829.2011.
Wirrig, E. E., Hinton, R. B., & Yutzey, K. E. (2011). Differential expression of cartilage and bone-related proteins in pediatric and adult diseased aortic valves. Journal of Molecular and Cellular Cardiology, 50(3), 561–569. doi:10.1016/j.yjmcc.2010.12.005.
Cujec, B., & Pollick, C. (1988). Isolated thickening of one aortic cusp: preferential thickening of the noncoronary cusp. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 1(6), 430–432.
Back, M., Gasser, T. C., Michel, J. B., & Caligiuri, G. (2013). Biomechanical factors in the biology of aortic wall and aortic valve diseases. Cardiovascular Research. doi:10.1093/cvr/cvt040.
Liu, G. R. SSQ. (2013). The finite element method—a practical course, 2nd edition. Elsevier (BH).
Croft L. R., & Kaazempur Mofrad, M. R. (2010). Computational modeling of the aortic heart valves—computational modeling in biomechanics, Chapter 7. :221–252
Liu G. R., & Trung, N. T. (2010). Smoothed finite element methods. CRC.
He, Z. C., Liu, G. R., Zhong, Z. H., Zhang, G. Y., & Cheng, A. G. (2011). A coupled ES-FEM/BEM method for fluid-structure interaction problems. Engineering of Analysis and Boundary Elements, 35(1), 140–147. doi:10.1016/j.enganabound.2010.05.003.
Wang, S., Khoo, B. C., Liu, G. R., & Xu, G. X. (2013). An arbitrary Lagrangian-Eulerian gradient smoothing method (GSM/ALE) for interaction of fluid and a moving rigid body. Computers & Fluids, 71, 327–347. doi:10.1016/j.compfluid.2012.10.028.
Zhang, Z. Q., Yao, J. Y., & Liu, G. R. (2011). An immersed smoothed finite element method for fluid-structure interaction problems. International Journal of Computers Meth-Sing, 8(4), 747–757. doi:10.1142/S0219876211002794.
Pasta, S., Rinaudo, A., Luca, A., Pilato, M., Scardulla, C., Gleason, T. G., & Vorp, D. A. (2013). Difference in hemodynamic and wall stress of ascending thoracic aortic aneurysms with bicuspid and tricuspid aortic valve. Journal of Biomechanics, 46(10), 1729–1738. doi:10.1016/j.jbiomech.2013.03.029.
Saber, N. R., Wood, N. B., Gosman, A. D., Merrifield, R. D., Yang, G. Z., Charrier, C. L., Gatehouse, P. D., & Firmin, D. N. (2003). Progress towards patient-specific computational flow modeling of the left heart via combination of magnetic resonance imaging with computational fluid dynamics. Annals of Biomedical Engineering, 31(1), 42–52.
Yao, J. Y., Liu, G. R., Narmoneva, D. A., Hinton, R. B., & Zhang, Z. Q. (2012). Immersed smoothed finite element method for fluid-structure interaction simulation of aortic valves. Computational Mechanics, 50(6), 789–804. doi:10.1007/s00466-012-0781-z.
Liu, G. R. (2009). Meshfree methods: moving beyond the finite element method. 2nd Edition. CRC.
Wagenseil, J. E., & Mecham, R. P. (2009). Vascular extracellular matrix and arterial mechanics. Physiological Reviews, 89(3), 957–989. doi:10.1152/physrev.00041.2008.
Tsamis, A., Krawiec, J. T., & Vorp, D. A. (2013). Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review. Journal of the Royal Society, Interface the Royal Society, 10(83), 20121004. doi:10.1098/rsif.2012.1004.
Sewell-Loftin, M. K., Brown, C. B., Baldwin, H. S., & Merryman, W. D. (2012). A novel technique for quantifying mouse heart valve leaflet stiffness with atomic force microscopy. The Journal of Heart Valve Disease, 21(4), 513–520.
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., 3rd, Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., Sundt, T. M., 3rd, Thomas, J. D., Anderson, J. L., Halperin, J. L., Albert, N. M., Bozkurt, B., Brindis, R. G., Creager, M. A., Curtis, L. H., DeMets, D., Guyton, R. A., Hochman, J. S., Kovacs, R. J., Ohman, E. M., Pressler, S. J., Sellke, F. W., Shen, W. K., Stevenson, W. G., Yancy, C. W., American College of C, American College of Cardiology/American Heart A, & American Heart A. (2014). 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of Thoracic and Cardiovascular Surgery, 148(1), e1–e132. doi:10.1016/j.jtcvs.2014.05.014.
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., Stewart, W. J., Waggoner, A., & Weissman, N. J. (2003). Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 16(7), 777–802. doi:10.1016/S0894-7317(03)00335-3.
Baumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Evangelista, A., Griffin, B. P., Iung, B., Otto, C. M., Pellikka, P. A., & Quinones, M. (2009). Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 22(1), 1–23. doi:10.1016/j.echo.2008.11.029. quiz 101–102.
Gott, V. L., Alejo, D. E., & Cameron, D. E. (2003). Mechanical heart valves: 50 years of evolution. The Annals of Thoracic Surgery, 76(6), S2230–S2239.
Gallegos, R. P. (2006). Selection of prosthetic heart valves. Current Treat Options Cardiovascular Medicine, 8(6), 443–452.
Sacks, M. S., Mirnajafi, A., Sun, W., & Schmidt, P. (2006). Bioprosthetic heart valve heterograft biomaterials: structure, mechanical behavior and computational simulation. Expert Review of Medical Devices, 3(6), 817–834. doi:10.1586/17434440.3.6.817.
Bailey, M. T., Pillarisetti, S., Xiao, H., & Vyavahare, N. R. (2003). Role of elastin in pathologic calcification of xenograft heart valves. Journal of Biomedical Materials Research. Part A, 66(1), 93–102. doi:10.1002/jbm.a.10543.
Vyavahare, N., Ogle, M., Schoen, F. J., Zand, R., Gloeckner, D. C., Sacks, M., & Levy, R. J. (1999). Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. Journal of Biomedial Materials Research, 46(1), 44–50.
Vesely, I. (2005). Heart valve tissue engineering. Circulation Research, 97(8), 743–755. doi:10.1161/01.RES.0000185326.04010.9f.
Svensson, L. G., Blackstone, E. H., & Cosgrove, D. M., 3rd. (2003). Surgical options in young adults with aortic valve disease. Current Problems in Cardiology, 28(7), 417–480. doi:10.1016/j.cpcardiol.2003.08.002.
Nowrangi, S. K., Connolly, H. M., Freeman, W. K., & Click, R. L. (2001). Impact of intraoperative transesophageal echocardiography among patients undergoing aortic valve replacement for aortic stenosis. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 14(9), 863–866.
Svensson, L. G., Deglurkar, I., Ung, J., Pettersson, G., Gillinov, A. M., D’Agostino, R. S., & Lytle, B. W. (2007). Aortic valve repair and root preservation by remodeling, reimplantation, and tailoring: technical aspects and early outcome. Journal of Cardiac Surgery, 22(6), 473–479. doi:10.1111/j.1540-8191.2007.00467.x.
Svensson, L. G. (2008). Aortic valve stenosis and regurgitation: an overview of management. The Journal of Cardiovascular Surgery, 49(2), 297–303.
Piazza, N., Bleiziffer, S., Brockmann, G., Hendrick, R., Deutsch, M. A., Opitz, A., Mazzitelli, D., Tassani-Prell, P., Schreiber, C., & Lange, R. (2011). Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 1). JACC. Cardiovascular Interventions, 4(7), 721–732. doi:10.1016/j.jcin.2011.03.016.
Hinton, R. B. (2014). Advances in the treatment of aortic valve disease: is it time for companion diagnostics? Current Opinion in Pediatrics. doi:10.1097/MOP.0000000000000137.
Piazza, N., Bleiziffer, S., Brockmann, G., Hendrick, R., Deutsch, M. A., Opitz, A., Mazzitelli, D., Tassani-Prell, P., Schreiber, C., & Lange, R. (2011). Transcatheter aortic valve implantation for failing surgical aortic bioprosthetic valve: from concept to clinical application and evaluation (part 2). JACC. Cardiovascular Interventions, 4(7), 733–742. doi:10.1016/j.jcin.2011.05.007.
Zoghbi, W. A., Chambers, J. B., Dumesnil, J. G., Foster, E., Gottdiener, J. S., Grayburn, P. A., Khandheria, B. K., Levine, R. A., Marx, G. R., Miller, F. A., Jr., Nakatani, S., Quinones, M. A., Rakowski, H., Rodriguez, L. L., Swaminathan, M., Waggoner, A. D., Weissman, N. J., & Zabalgoitia, M. (2009). Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 22(9), 975–1014. doi:10.1016/j.echo.2009.07.013. quiz 1082–1014.
Sugeng, L., Shernan, S. K., Weinert, L., Shook, D., Raman, J., Jeevanandam, V., DuPont, F., Fox, J., Mor-Avi, V., & Lang, R. M. (2008). Real-time three-dimensional transesophageal echocardiography in valve disease: comparison with surgical findings and evaluation of prosthetic valves. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 21(12), 1347–1354. doi:10.1016/j.echo.2008.09.006.
Davies, R. R., Goldstein, L. J., Coady, M. A., Tittle, S. L., Rizzo, J. A., Kopf, G. S., & Elefteriades, J. A. (2002). Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. The Annals of Thoracic Surgery, 73(1), 17–27. discussion 27–18.
Loeys, B. L., Schwarze, U., Holm, T., Callewaert, B. L., Thomas, G. H., Pannu, H., De Backer, J. F., Oswald, G. L., Symoens, S., Manouvrier, S., Roberts, A. E., Faravelli, F., Greco, M. A., Pyeritz, R. E., Milewicz, D. M., Coucke, P. J., Cameron, D. E., Braverman, A. C., Byers, P. H., De Paepe, A. M., & Dietz, H. C. (2006). Aneurysm syndromes caused by mutations in the TGF-beta receptor. New England Journal of Medicine, 355(8), 788–798. doi:10.1056/NEJMoa055695.
Pannu, H., Tran-Fadulu, V., Papke, C. L., Scherer, S., Liu, Y., Presley, C., Guo, D., Estrera, A. L., Safi, H. J., Brasier, A. R., Vick, G. W., Marian, A. J., Raman, C. S., Buja, L. M., & Milewicz, D. M. (2007). MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Human Molecular Genetics, 16(20), 2453–2462. doi:10.1093/hmg/ddm201.
Shores, J., Berger, K. R., Murphy, E. A., & Pyeritz, R. E. (1994). Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. New England Journal of Medicine, 330(19), 1335–1341. doi:10.1056/NEJM199405123301902.
Brooke, B. S., Habashi, J. P., Judge, D. P., Patel, N., Loeys, B., & Dietz, H. C., 3rd. (2008). Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome. New England Journal of Medicine, 358(26), 2787–2795. doi:10.1056/NEJMoa0706585.
Svensson, L. G., Longoria, J., Kimmel, W. A., & Nadolny, E. (2000). Management of aortic valve disease during aortic surgery. The Annals of Thoracic Surgery, 69(3), 778–783. discussion 783–774.
Zehr, K. J., Orszulak, T. A., Mullany, C. J., Matloobi, A., Daly, R. C., Dearani, J. A., Sundt, T. M., 3rd, Puga, F. J., Danielson, G. K., & Schaff, H. V. (2004). Surgery for aneurysms of the aortic root: a 30-year experience. Circulation, 110(11), 1364–1371. doi:10.1161/01.CIR.0000141593.05085.87.
David, T. E., Feindel, C. M., Webb, G. D., Colman, J. M., Armstrong, S., & Maganti, M. (2007). Aortic valve preservation in patients with aortic root aneurysm: results of the reimplantation technique. The Annals of Thoracic Surgery, 83(2), S732–S735. doi:10.1016/j.athoracsur.2006.10.080. discussion S785-790.
Patel, N. D., Weiss, E. S., Alejo, D. E., Nwakanma, L. U., Williams, J. A., Dietz, H. C., Spevak, P. J., Gott, V. L., Vricella, L. A., & Cameron, D. E. (2008). Aortic root operations for Marfan syndrome: a comparison of the Bentall and valve-sparing procedures. The Annals of Thoracic Surgery, 85(6), 2003–2010. doi:10.1016/j.athoracsur.2008.01.032. discussion 2010–2001.
Greenberg, R. K., Haddad, F., Svensson, L., O’Neill, S., Walker, E., Lyden, S. P., Clair, D., & Lytle, B. (2005). Hybrid approaches to thoracic aortic aneurysms: the role of endovascular elephant trunk completion. Circulation, 112(17), 2619–2626. doi:10.1161/CIRCULATIONAHA.105.552398.
Stephens, E. H., Kearney, D. L., & Grande-Allen, K. J. (2012). Insight into pathologic abnormalities in congenital semilunar valve disease based on advances in understanding normal valve microstructure and extracellular matrix. Cardiovascular Pathology: The Official Journal of the Society for Cardiovascular Pathology, 21(1), 46–58. doi:10.1016/j.carpath.2011.01.002.
Stypmann, J., Glaser, K., Roth, W., Tobin, D. J., Petermann, I., Matthias, R., Monnig, G., Haverkamp, W., Breithardt, G., Schmahl, W., Peters, C., & Reinheckel, T. (2002). Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proceedings of the National Academy of Sciences of the United States of America, 99(9), 6234–6239. doi:10.1073/pnas.092637699.
Qayyum, S. R., Webb, S., Anderson, R. H., Verbeek, F. J., Brown, N. A., & Richardson, M. K. (2001). Septation and valvar formation in the outflow tract of the embryonic chick heart. Anatomical Record, 264(3), 273–283.
Chen, J. H., & Simmons, C. A. (2011). Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circulation Research, 108(12), 1510–1524. doi:10.1161/CIRCRESAHA.110.234237.
Schoen, F. J. (2012). Mechanisms of function and disease of natural and replacement heart valves. Annual Review of Pathology, 7, 161–183. doi:10.1146/annurev-pathol-011110-130257.
Bashur, C. A., Venkataraman, L., & Ramamurthi, A. (2012). Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly. Tissue Engineering. Part B, Reviews, 18(3), 203–217. doi:10.1089/ten.TEB.2011.0521.
Pasquali-Ronchetti, I., Baccarani-Contri, M., Young, R. D., Vogel, A., Steinmann, B., & Royce, P. M. (1994). Ultrastructural analysis of skin and aorta from a patient with Menkes disease. Experimental and Molecular Pathology, 61(1), 36–57. doi:10.1006/exmp.1994.1024.
Schildmeyer, L. A., Braun, R., Taffet, G., Debiasi, M., Burns, A. E., Bradley, A., & Schwartz, R. J. (2000). Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB Journal, 14(14), 2213–2220. doi:10.1096/fj.99-0927com.
Zhou, H. M., Weskamp, G., Chesneau, V., Sahin, U., Vortkamp, A., Horiuchi, K., Chiusaroli, R., Hahn, R., Wilkes, D., Fisher, P., Baron, R., Manova, K., Basson, C. T., Hempstead, B., & Blobel, C. P. (2004). Essential role for ADAM19 in cardiovascular morphogenesis. Molecular and Cellular Biology, 24(1), 96–104.
Dupuis, L. E., McCulloch, D. R., McGarity, J. D., Bahan, A., Wessels, A., Weber, D., Diminich, A. M., Nelson, C. M., Apte, S. S., & Kern, C. B. (2011). Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. Developmental Biology, 357(1), 152–164. doi:10.1016/j.ydbio.2011.06.041.
Dupuis, L. E., Osinska, H., Weinstein, M. B., Hinton, R. B., & Kern, C. B. (2013). Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves. Journal of Molecular and Cellular Cardiology, 60, 50–59. doi:10.1016/j.yjmcc.2013.03.010.
Tanaka, K., Sata, M., Fukuda, D., Suematsu, Y., Motomura, N., Takamoto, S., Hirata, Y., & Nagai, R. (2005). Age-associated aortic stenosis in apolipoprotein E-deficient mice. Journal of the American College of Cardiology, 46(1), 134–141. doi:10.1016/j.jacc.2005.03.058.
Aikawa, E., Nahrendorf, M., Sosnovik, D., Lok, V. M., Jaffer, F. A., Aikawa, M., & Weissleder, R. (2007). Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation, 115(3), 377–386. doi:10.1161/CIRCULATIONAHA.106.654913.
Drolet, M. C., Roussel, E., Deshaies, Y., Couet, J., & Arsenault, M. (2006). A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6J mice. Journal of the American College of Cardiology, 47(4), 850–855. doi:10.1016/j.jacc.2005.09.049.
Yoshioka, M., Yuasa, S., Matsumura, K., Kimura, K., Shiomi, T., Kimura, N., Shukunami, C., Okada, Y., Mukai, M., Shin, H., Yozu, R., Sata, M., Ogawa, S., Hiraki, Y., & Fukuda, K. (2006). Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nature Medicine, 12(10), 1151–1159. doi:10.1038/nm1476.
Rahkonen, O., Su, M., Hakovirta, H., Koskivirta, I., Hormuzdi, S. G., Vuorio, E., Bornstein, P., & Penttinen, R. (2004). Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture. Circulation Research, 94(1), 83–90. doi:10.1161/01.RES.0000108263.74520.15.
Liu, X., Wu, H., Byrne, M., Krane, S., & Jaenisch, R. (1997). Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proceedings of the National Academy of Sciences of the United States of America, 94(5), 1852–1856.
Smith, L. B., Hadoke, P. W., Dyer, E., Denvir, M. A., Brownstein, D., Miller, E., Nelson, N., Wells, S., Cheeseman, M., & Greenfield, A. (2011). Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome. Cardiovascular Research, 90(1), 182–190. doi:10.1093/cvr/cvq356.
Sukhova, G. K., Wang, B., Libby, P., Pan, J. H., Zhang, Y., Grubb, A., Fang, K., Chapman, H. A., & Shi, G. P. (2005). Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circulation Research, 96(3), 368–375. doi:10.1161/01.RES.0000155964.34150.F7.
Barrick, C. J., Roberts, R. B., Rojas, M., Rajamannan, N. M., Suitt, C. B., O’Brien, K. D., Smyth, S. S., & Threadgill, D. W. (2009). Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6 J but not 129S1/SvImJ mice. American Journal of Physiology. Heart and Circulatory Physiology, 297(1), H65–H75. doi:10.1152/ajpheart.00866.2008.
Zacchigna, L., Vecchione, C., Notte, A., Cordenonsi, M., Dupont, S., Maretto, S., Cifelli, G., Ferrari, A., Maffei, A., Fabbro, C., Braghetta, P., Marino, G., Selvetella, G., Aretini, A., Colonnese, C., Bettarini, U., Russo, G., Soligo, S., Adorno, M., Bonaldo, P., Volpin, D., Piccolo, S., Lembo, G., & Bressan, G. M. (2006). Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell, 124(5), 929–942. doi:10.1016/j.cell.2005.12.035.
Neptune, E. R., Frischmeyer, P. A., Arking, D. E., Myers, L., Bunton, T. E., Gayraud, B., Ramirez, F., Sakai, L. Y., & Dietz, H. C. (2003). Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nature Genetics, 33(3), 407–411. doi:10.1038/ng1116.
Judge, D. P., Biery, N. J., Keene, D. R., Geubtner, J., Myers, L., Huso, D. L., Sakai, L. Y., & Dietz, H. C. (2004). Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. The Journal of Clinical Investigation, 114(2), 172–181. doi:10.1172/JCI20641.
Misra, C., Sachan, N., McNally, C. R., Koenig, S. N., Nichols, H. A., Guggilam, A., Lucchesi, P. A., Pu, W. T., Srivastava, D., & Garg, V. (2012). Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo. PLoS Genetics, 8(5), e1002690. doi:10.1371/journal.pgen.1002690.
Laforest, B., Andelfinger, G., & Nemer, M. (2011). Loss of Gata5 in mice leads to bicuspid aortic valve. The Journal of Clinical Investigation, 121(7), 2876–2887. doi:10.1172/JCI44555.
Laforest, B., & Nemer, M. (2011). GATA5 interacts with GATA4 and GATA6 in outflow tract development. Developmental Biology, 358(2), 368–378. doi:10.1016/j.ydbio.2011.07.037.
Baldo, G., Wu, S., Howe, R. A., Ramamoothy, M., Knutsen, R. H., Fang, J., Mecham, R. P., Liu, Y., Wu, X., Atkinson, J. P., & Ponder, K. P. (2011). Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation. Molecular Genetics and Metabolism, 104(4), 608–619. doi:10.1016/j.ymgme.2011.08.018.
Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G., Nanba, D., Higashiyama, S., Hori, M., Klagsbrun, M., & Mekada, E. (2003). Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proceedings of the National Academy of Sciences of the United States of America, 100(6), 3221–3226. doi:10.1073/pnas.0537588100.
Sassan HajMohammadi, J. S., Silvio, L., Palac, R. T., & Shworak, N. W. (2003). Mice with reduced anticoagulant heparan sulfate develop Myxomatous valvular degeneration. Annual Conference, Arterioscler Thrombosis Vascular Biology, 23(5), a-2.
Makki, N., & Capecchi, M. R. (2012). Cardiovascular defects in a mouse model of HOXA1 syndrome. Human Molecular Genetics, 21(1), 26–31. doi:10.1093/hmg/ddr434.
Chowdhury, B., Hemming, R., Hombach-Klonisch, S., Flamion, B., & Triggs-Raine, B. (2013). Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction. Journal of Biological Chemistry, 288(1), 520–528. doi:10.1074/jbc.M112.393629.
Ma, X., Tittiger, M., Knutsen, R. H., Kovacs, A., Schaller, L., Mecham, R. P., & Ponder, K. P. (2008). Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice. Molecular Genetics and Metabolism, 94(3), 298–304. doi:10.1016/j.ymgme.2008.03.018.
Jordan, M. C., Zheng, Y., Ryazantsev, S., Rozengurt, N., Roos, K. P., & Neufeld, E. F. (2005). Cardiac manifestations in the mouse model of mucopolysaccharidosis I. Molecular Genetics and Metabolism, 86(1–2), 233–243. doi:10.1016/j.ymgme.2005.05.003.
Arnold, T. D., Zang, K., & Vallejo-Illarramendi, A. (2013). Deletion of integrin-linked kinase from neural crest cells in mice results in aortic aneurysms and embryonic lethality. Disease Models & Mechanisms, 6(5), 1205–1212. doi:10.1242/dmm.011866.
Isoda, K., Matsuki, T., Kondo, H., Iwakura, Y., & Ohsuzu, F. (2010). Deficiency of interleukin-1 receptor antagonist induces aortic valve disease in BALB/c mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(4), 708–715. doi:10.1161/ATVBAHA.109.201749.
High, F. A., Jain, R., Stoller, J. Z., Antonucci, N. B., Lu, M. M., Loomes, K. M., Kaestner, K. H., Pear, W. S., & Epstein, J. A. (2009). Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. Journal of Clinical Investigation, 119(7), 1986–1996. doi:10.1172/JCI38922.
Matsumoto, Y., Adams, V., Jacob, S., Mangner, N., Schuler, G., & Linke, A. (2010). Regular exercise training prevents aortic valve disease in low-density lipoprotein-receptor-deficient mice. Circulation, 121(6), 759–767. doi:10.1161/CIRCULATIONAHA.109.892224.
Weiss, R. M., Ohashi, M., Miller, J. D., Young, S. G., & Heistad, D. D. (2006). Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation, 114(19), 2065–2069. doi:10.1161/CIRCULATIONAHA.106.634139.
Varga, R., Eriksson, M., Erdos, M. R., Olive, M., Harten, I., Kolodgie, F., Capell, B. C., Cheng, J., Faddah, D., Perkins, S., Avallone, H., San, H., Qu, X., Ganesh, S., Gordon, L. B., Virmani, R., Wight, T. N., Nabel, E. G., & Collins, F. S. (2006). Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences of the United States of America, 103(9), 3250–3255. doi:10.1073/pnas.0600012103.
Galvin, K. M., Donovan, M. J., Lynch, C. A., Meyer, R. I., Paul, R. J., Lorenz, J. N., Fairchild-Huntress, V., Dixon, K. L., Dunmore, J. H., Gimbrone, M. A., Jr., Falb, D., & Huszar, D. (2000). A role for smad6 in development and homeostasis of the cardiovascular system. Nature Genetics, 24(2), 171–174. doi:10.1038/72835.
Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., & Karsenty, G. (1997). Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature, 386(6620), 78–81. doi:10.1038/386078a0.
Kuang, S. Q., Kwartler, C. S., Byanova, K. L., Pham, J., Gong, L., Prakash, S. K., Huang, J., Kamm, K. E., Stull, J. T., Sweeney, H. L., & Milewicz, D. M. (2012). Rare, nonsynonymous variant in the smooth muscle-specific isoform of myosin heavy chain, MYH11, R247C, alters force generation in the aorta and phenotype of smooth muscle cells. Circulation Research, 110(11), 1411–1422. doi:10.1161/CIRCRESAHA.111.261743.
Biben, C., Weber, R., Kesteven, S., Stanley, E., McDonald, L., Elliott, D. A., Barnett, L., Koentgen, F., Robb, L., Feneley, M., & Harvey, R. P. (2000). Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circulation Research, 87(10), 888–895.
Lee, T. C., Zhao, Y. D., Courtman, D. W., & Stewart, D. J. (2000). Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation, 101(20), 2345–2348.
Bosse, K., Hans, C. P., Zhao, N., Koenig, S. N., Huang, N., Guggilam, A., LaHaye, S., Tao, G., Lucchesi, P. A., Lincoln, J., Lilly, B., & Garg, V. (2013). Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease. Journal of Molecular and Cellular Cardiology, 60, 27–35. doi:10.1016/j.yjmcc.2013.04.001.
Nigam, V., & Srivastava, D. (2009). Notch1 represses osteogenic pathways in aortic valve cells. Journal of Molecular and Cellular Cardiology, 47(6), 828–834. doi:10.1016/j.yjmcc.2009.08.008.
Jain, R., Engleka, K. A., Rentschler, S. L., Manderfield, L. J., Li, L., Yuan, L., & Epstein, J. A. (2011). Cardiac neural crest orchestrates remodeling and functional maturation of mouse semilunar valves. The Journal of Clinical Investigation, 121(1), 422–430. doi:10.1172/JCI44244.
Kurbegovic, A., Cote, O., Couillard, M., Ward, C. J., Harris, P. C., & Trudel, M. (2010). Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes. Human Molecular Genetics, 19(7), 1174–1189. doi:10.1093/hmg/ddp588.
Cheng, C. H., Kikuchi, T., Chen, Y. H., Sabbagha, N. G., Lee, Y. C., Pan, H. J., Chang, C., & Chen, Y. T. (2009). Mutations in the SLC2A10 gene cause arterial abnormalities in mice. Cardiovascular Research, 81(2), 381–388. doi:10.1093/cvr/cvn319.
Peacock, J. D., Levay, A. K., Gillaspie, D. B., Tao, G., & Lincoln, J. (2010). Reduced sox9 function promotes heart valve calcification phenotypes in vivo. Circulation Research, 106(4), 712–719. doi:10.1161/CIRCRESAHA.109.213702.
Sanford, L. P., Ormsby, I., Gittenberger-de Groot, A. C., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997). TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development, 124(13), 2659–2670.
Chakraborty, S., Wirrig, E. E., Hinton, R. B., Merrill, W. H., Spicer, D. B., & Yutzey, K. E. (2010). Twist1 promotes heart valve cell proliferation and extracellular matrix gene expression during development in vivo and is expressed in human diseased aortic valves. Developmental Biology, 347(1), 167–179. doi:10.1016/j.ydbio.2010.08.021.
Bonachea, E. M., Zender, G., White, P., Corsmeier, D., Newsom, D., Fitzgerald-Butt, S., Garg, V., & McBride, K. L. (2014). Use of a targeted, combinatorial next-generation sequencing approach for the study of bicuspid aortic valve. BMC Medical Genomics, 7, 56. doi:10.1186/1755-8794-7-56.
Bonachea, E. M., Chang, S. W., Zender, G., LaHaye, S., Fitzgerald-Butt, S., McBride, K. L., & Garg, V. (2014). Rare GATA5 sequence variants identified in individuals with bicuspid aortic valve. Pediatric Research, 76(2), 211–216. doi:10.1038/pr.2014.67.
Ankeny, R. F., Thourani, V. H., Weiss, D., Vega, J. D., Taylor, W. R., Nerem, R. M., & Jo, H. (2011). Preferential activation of SMAD1/5/8 on the fibrosa endothelium in calcified human aortic valves–association with low BMP antagonists and SMAD6. PLoS ONE, 6(6), e20969. doi:10.1371/journal.pone.0020969.
Caira, F. C., Stock, S. R., Gleason, T. G., McGee, E. C., Huang, J., Bonow, R. O., Spelsberg, T. C., McCarthy, P. M., Rahimtoola, S. H., & Rajamannan, N. M. (2006). Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. Journal of the American College of Cardiology, 47(8), 1707–1712. doi:10.1016/j.jacc.2006.02.040.
Rajamannan, N. M., Subramaniam, M., Caira, F., Stock, S. R., & Spelsberg, T. C. (2005). Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation, 112(9 Suppl), I229–I234. doi:10.1161/01.CIRCULATIONAHA.104.524306.
Alfieri, C. M., Cheek, J., Chakraborty, S., & Yutzey, K. E. (2010). Wnt signaling in heart valve development and osteogenic gene induction. Developmental Biology, 338(2), 127–135. doi:10.1016/j.ydbio.2009.11.030.
O’Brien, K. D. (2006). Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arteriosclerosis, Thrombosis, and Vascular Biology, 26(8), 1721–1728. doi:10.1161/01.ATV.0000227513.13697.ac.
Holm, T. M., Habashi, J. P., Doyle, J. J., Bedja, D., Chen, Y., van Erp, C., Lindsay, M. E., Kim, D., Schoenhoff, F., Cohn, R. D., Loeys, B. L., Thomas, C. J., Patnaik, S., Marugan, J. J., Judge, D. P., & Dietz, H. C. (2011). Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science, 332(6027), 358–361. doi:10.1126/science.1192149.
Padang, R., Bagnall, R. D., Richmond, D. R., Bannon, P. G., & Semsarian, C. (2012). Rare non-synonymous variations in the transcriptional activation domains of GATA5 in bicuspid aortic valve disease. Journal of Molecular and Cellular Cardiology, 53(2), 277–281. doi:10.1016/j.yjmcc.2012.05.009.
Aicher, D., Urbich, C., Zeiher, A., Dimmeler, S., & Schafers, H. J. (2007). Endothelial nitric oxide synthase in bicuspid aortic valve disease. Annals of Thoracic Surgery, 83(4), 1290–1294. doi:10.1016/j.athoracsur.2006.11.086.
Girdauskas, E., Schulz, S., Borger, M. A., Mierzwa, M., & Kuntze, T. (2011). Transforming growth factor-beta receptor type II mutation in a patient with bicuspid aortic valve disease and intraoperative aortic dissection. Annals of Thoracic Surgery, 91(5), e70–e71. doi:10.1016/j.athoracsur.2010.12.060.
Kappetein, A. P., Gittenberger-de Groot, A. C., Zwinderman, A. H., Rohmer, J., Poelmann, R. E., & Huysmans, H. A. (1991). The neural crest as a possible pathogenetic factor in coarctation of the aorta and bicuspid aortic valve. Journal of Thoracic and Cardiovascular Surgery, 102(6), 830–836.
Kyndt, F., Gueffet, J. P., Probst, V., Jaafar, P., Legendre, A., Le Bouffant, F., Toquet, C., Roy, E., McGregor, L., Lynch, S. A., Newbury-Ecob, R., Tran, V., Young, I., Trochu, J. N., Le Marec, H., & Schott, J. J. (2007). Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation, 115(1), 40–49. doi:10.1161/CIRCULATIONAHA.106.622621.
Acknowledgments
We thank Andrew Stout and K. Jane Grande-Allen, PhD for helpful discussions.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Daniel P. Judge oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Krishnamurthy, V.K., Godby, R.C., Liu, G.R. et al. Review of Molecular and Mechanical Interactions in the Aortic Valve and Aorta: Implications for the Shared Pathogenesis of Aortic Valve Disease and Aortopathy. J. of Cardiovasc. Trans. Res. 7, 823–846 (2014). https://doi.org/10.1007/s12265-014-9602-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-014-9602-4